Imagion Biosystems Limited
IBXXF
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.24M
Close$
Share Statistics
| Market cap | $3.24 Million |
|---|---|
| Enterprise Value | $5.40 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.02 |
| Beta | -0.21 |
| Outstanding Shares | 490,471,687 |
Return
| Return on Equity | 199.77% |
|---|---|
| Return on Assets | -1016.59% |
| Return on Invested Capital | 165.33% |
Valuation & Multiples
| P/E Ratio | -0.53 |
|---|---|
| PEG | -2.76 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | 5.11 |
| Enterprise Value to EBIT | -0.95 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.41 |
| Debt to Equity | -0.64 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Imagion Biosystems Limited
11 employees
CEO: Robert Romeo Proulx Imagion Biosystems Limited operates as a medical imaging company that uses bio-safe magnetic nanoparticles to detect cancer and other diseases in Australia. The company is involved in nanotechnology; biotechnology; medical imaging using ...